what are the Biomarkers: Recommendation for Prevention of HF?
For patients at risk of developing HF, natriuretic peptide biomarker? based screening followed by team-based care, including a cardiovascular specialist optimizing GDMT, can be useful to prevent the development of left ventricular dysfunction (systolic or diastolic) or new-onset HF.